Ann: Investor Presentation, page-42

"if you know anything about the long term history of this, so far, unsuccessful company you'd know that with every change of management they have ever had and with every new direction they have taken, that it's always the same old story "We'll make it this time,""

This with the 10 year chart. So you are complaining about the shell that imu has moved into. What went on before is irrelevant to imu.

A bit like a business moving into an office and somebody coming up and saying the last two companies who moved into this office went bust - "you guys are rubbish, over the last ten years, blah, blah, blah....".

A good presentation I thought. More professional looking.

As for the B-Vaxx/HER-Vaxx crossover. B Vaxx is a good proof of concept of a B cell vaccine, but I believe HER-Vaxx produces better antibodies.

As for "Basic outline for phase 2, slide ten. Thoughts? on study having two end points..."

The two endpoints are standard, overall survival and progression free survival.

As is the case for the two arms, one with chemo and one with our drug combined with chemo. Pretty standard.

cheers